Treatment of Advanced Solid Tumor With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate the safety of TSA-CTL in the treatment of
the advanced melanoma.
The secondary purpose of this study is to evaluate preliminarily the effect of TSA-CTL in the
treatment of the advanced melanoma.